An exaggerated emotional brain response to nonthreatening, nonemotional cues at age 14 predicted the onset of psychosis symptoms within the next 2 years.
RP5063, a dopamine serotonin stabilizer, was associated with symptom improvement in adults with acute exacerbation of schizophrenia or schizoaffective disorder.
A study was conducted to determine the accuracy of patient symptom documentation in electronic medical records compared to self-reported symptom questionnaires.
In a recent meta-analysis, researchers investigated the risk of gastrointestinal bleeding with daily aspirin use, specifically examining the risk of fatal events attributable to low-dose aspirin.